Inotrem and the Crohn’s & Colitis Foundation sign a R&D collaboration agreement to support the development of a new therapeutic approach in Inflammatory Bowel Disease (IBD)
GeNeuro : information financière du 1er trimestre 2022
Ribonexus obtient 2 millions d’euros d’aides de Bpifrance dans le cadre du Plan Deeptech
Coave Therapeutics to Present at Cell & Gene Meeting on the Mediterranean